Bromine in PDB 8dea: Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
Enzymatic activity of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
All present enzymatic activity of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors:
3.4.21.46;
Protein crystallography data
The structure of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors, PDB code: 8dea
was solved by
K.Raman,
Y.S.Babu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.46 /
2.21
|
Space group
|
P 2 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
44.898,
73.032,
240.864,
90,
90,
90
|
R / Rfree (%)
|
22.5 /
30
|
Bromine Binding Sites:
The binding sites of Bromine atom in the Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
(pdb code 8dea). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the
Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors, PDB code: 8dea:
Jump to Bromine binding site number:
1;
2;
3;
4;
Bromine binding site 1 out
of 4 in 8dea
Go back to
Bromine Binding Sites List in 8dea
Bromine binding site 1 out
of 4 in the Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br301
b:28.1
occ:1.00
|
BR20
|
A:R7X301
|
0.0
|
28.1
|
1.0
|
C19
|
A:R7X301
|
2.0
|
29.5
|
1.0
|
N21
|
A:R7X301
|
2.9
|
31.5
|
1.0
|
C18
|
A:R7X301
|
3.0
|
28.3
|
1.0
|
O
|
A:TRP128
|
3.4
|
20.1
|
1.0
|
O
|
A:HOH403
|
3.8
|
24.6
|
1.0
|
CA
|
A:GLY129
|
3.8
|
22.5
|
1.0
|
CD2
|
A:HIS24
|
3.9
|
30.3
|
1.0
|
CA
|
A:GLY181
|
3.9
|
24.5
|
1.0
|
CG
|
A:ARG137
|
4.0
|
34.1
|
1.0
|
C
|
A:GLY129
|
4.1
|
22.8
|
1.0
|
CZ
|
A:ARG137
|
4.1
|
42.4
|
1.0
|
N
|
A:ILE130
|
4.2
|
25.2
|
1.0
|
O
|
A:LYS180
|
4.2
|
25.6
|
1.0
|
C15
|
A:R7X301
|
4.2
|
30.5
|
1.0
|
C17
|
A:R7X301
|
4.2
|
29.4
|
1.0
|
C
|
A:TRP128
|
4.3
|
20.4
|
1.0
|
NH1
|
A:ARG137
|
4.3
|
44.7
|
1.0
|
CG2
|
A:ILE130
|
4.3
|
26.1
|
1.0
|
NH2
|
A:ARG137
|
4.4
|
41.8
|
1.0
|
NE
|
A:ARG137
|
4.4
|
40.3
|
1.0
|
N
|
A:GLY129
|
4.5
|
20.4
|
1.0
|
NE2
|
A:HIS24
|
4.5
|
29.1
|
1.0
|
CD
|
A:ARG137
|
4.6
|
36.6
|
1.0
|
CB
|
A:ARG137
|
4.6
|
32.9
|
1.0
|
O
|
A:HIS24
|
4.6
|
27.1
|
1.0
|
N
|
A:GLY181
|
4.7
|
24.0
|
1.0
|
C16
|
A:R7X301
|
4.7
|
30.7
|
1.0
|
O
|
A:GLY129
|
4.8
|
23.0
|
1.0
|
C
|
A:GLY181
|
4.8
|
21.5
|
1.0
|
C
|
A:LYS180
|
4.8
|
26.0
|
1.0
|
O
|
A:GLY181
|
4.9
|
20.4
|
1.0
|
CA
|
A:ILE130
|
4.9
|
26.1
|
1.0
|
CA
|
A:ARG137
|
5.0
|
34.2
|
1.0
|
|
Bromine binding site 2 out
of 4 in 8dea
Go back to
Bromine Binding Sites List in 8dea
Bromine binding site 2 out
of 4 in the Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br301
b:34.3
occ:1.00
|
BR20
|
B:R7X301
|
0.0
|
34.3
|
1.0
|
C19
|
B:R7X301
|
1.9
|
28.8
|
1.0
|
N21
|
B:R7X301
|
2.8
|
27.6
|
1.0
|
C18
|
B:R7X301
|
2.9
|
28.9
|
1.0
|
O
|
B:TRP128
|
3.3
|
24.6
|
1.0
|
CA
|
B:GLY129
|
3.8
|
26.1
|
1.0
|
CG
|
B:ARG137
|
3.9
|
37.1
|
1.0
|
N
|
B:ILE130
|
3.9
|
24.4
|
1.0
|
CD2
|
B:HIS24
|
4.0
|
27.8
|
1.0
|
CA
|
B:GLY181
|
4.0
|
27.3
|
1.0
|
C
|
B:GLY129
|
4.0
|
24.4
|
1.0
|
O
|
B:LYS180
|
4.1
|
28.9
|
1.0
|
C15
|
B:R7X301
|
4.1
|
29.5
|
1.0
|
O
|
B:HOH407
|
4.1
|
23.3
|
1.0
|
C17
|
B:R7X301
|
4.1
|
28.0
|
1.0
|
CG2
|
B:ILE130
|
4.2
|
26.3
|
1.0
|
C
|
B:TRP128
|
4.2
|
25.7
|
1.0
|
CZ
|
B:ARG137
|
4.3
|
36.8
|
1.0
|
NE
|
B:ARG137
|
4.3
|
43.4
|
1.0
|
NH1
|
B:ARG137
|
4.3
|
32.9
|
1.0
|
CD
|
B:ARG137
|
4.4
|
39.0
|
1.0
|
N
|
B:GLY129
|
4.5
|
24.2
|
1.0
|
CB
|
B:ARG137
|
4.6
|
36.2
|
1.0
|
NE2
|
B:HIS24
|
4.6
|
24.1
|
1.0
|
C16
|
B:R7X301
|
4.6
|
28.1
|
1.0
|
C
|
B:LYS180
|
4.7
|
30.0
|
1.0
|
N
|
B:GLY181
|
4.7
|
26.9
|
1.0
|
CA
|
B:ILE130
|
4.8
|
24.4
|
1.0
|
O
|
B:HIS24
|
4.8
|
30.2
|
1.0
|
O
|
B:GLY129
|
4.8
|
28.0
|
1.0
|
NH2
|
B:ARG137
|
4.8
|
38.4
|
1.0
|
C
|
B:GLY181
|
4.9
|
26.7
|
1.0
|
CA
|
B:ARG137
|
4.9
|
37.1
|
1.0
|
|
Bromine binding site 3 out
of 4 in 8dea
Go back to
Bromine Binding Sites List in 8dea
Bromine binding site 3 out
of 4 in the Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Br301
b:31.5
occ:1.00
|
BR20
|
C:R7X301
|
0.0
|
31.5
|
1.0
|
C19
|
C:R7X301
|
1.9
|
27.6
|
1.0
|
N21
|
C:R7X301
|
2.9
|
29.0
|
1.0
|
C18
|
C:R7X301
|
2.9
|
27.6
|
1.0
|
O
|
C:TRP128
|
3.3
|
26.7
|
1.0
|
ND1
|
C:HIS24
|
3.7
|
26.0
|
1.0
|
O
|
C:LYS180
|
4.0
|
27.2
|
1.0
|
CA
|
C:GLY129
|
4.0
|
26.2
|
1.0
|
CA
|
C:GLY181
|
4.1
|
28.0
|
1.0
|
N
|
C:ILE130
|
4.1
|
24.9
|
1.0
|
CE1
|
C:HIS24
|
4.2
|
24.3
|
1.0
|
CG
|
C:ARG137
|
4.2
|
37.1
|
1.0
|
C15
|
C:R7X301
|
4.2
|
29.1
|
1.0
|
C
|
C:GLY129
|
4.2
|
23.8
|
1.0
|
C17
|
C:R7X301
|
4.2
|
26.5
|
1.0
|
C
|
C:TRP128
|
4.3
|
25.9
|
1.0
|
CG2
|
C:ILE130
|
4.3
|
26.1
|
1.0
|
O
|
C:HOH405
|
4.3
|
24.0
|
1.0
|
CB
|
C:ARG137
|
4.5
|
34.1
|
1.0
|
NE
|
C:ARG137
|
4.5
|
42.1
|
1.0
|
O
|
C:HIS24
|
4.6
|
29.6
|
1.0
|
N
|
C:GLY129
|
4.6
|
24.4
|
1.0
|
C
|
C:LYS180
|
4.7
|
28.9
|
1.0
|
C16
|
C:R7X301
|
4.7
|
27.0
|
1.0
|
N
|
C:GLY181
|
4.8
|
28.5
|
1.0
|
CZ
|
C:ARG137
|
4.8
|
41.0
|
1.0
|
CG
|
C:HIS24
|
4.9
|
24.8
|
1.0
|
CA
|
C:ILE130
|
4.9
|
27.3
|
1.0
|
CA
|
C:ARG137
|
4.9
|
32.2
|
1.0
|
NH2
|
C:ARG137
|
4.9
|
39.6
|
1.0
|
O
|
C:GLY129
|
5.0
|
24.4
|
1.0
|
C
|
C:GLY181
|
5.0
|
28.9
|
1.0
|
CD
|
C:ARG137
|
5.0
|
41.3
|
1.0
|
|
Bromine binding site 4 out
of 4 in 8dea
Go back to
Bromine Binding Sites List in 8dea
Bromine binding site 4 out
of 4 in the Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Br301
b:39.4
occ:1.00
|
BR20
|
D:R7X301
|
0.0
|
39.4
|
1.0
|
C19
|
D:R7X301
|
2.0
|
43.2
|
1.0
|
N21
|
D:R7X301
|
2.9
|
48.6
|
1.0
|
C18
|
D:R7X301
|
3.0
|
42.6
|
1.0
|
O
|
D:TRP128
|
3.6
|
27.1
|
1.0
|
CG
|
D:ARG137
|
3.7
|
47.2
|
1.0
|
ND1
|
D:HIS24
|
3.9
|
32.6
|
1.0
|
NE
|
D:ARG137
|
3.9
|
57.2
|
1.0
|
CA
|
D:GLY129
|
3.9
|
30.4
|
1.0
|
CD1
|
D:ILE130
|
4.0
|
40.0
|
1.0
|
O
|
D:LYS180
|
4.0
|
30.3
|
1.0
|
CZ
|
D:ARG137
|
4.1
|
54.8
|
1.0
|
N
|
D:ILE130
|
4.1
|
32.7
|
1.0
|
CD
|
D:ARG137
|
4.2
|
49.6
|
1.0
|
CB
|
D:ARG137
|
4.2
|
43.4
|
1.0
|
CA
|
D:GLY181
|
4.2
|
26.7
|
1.0
|
C
|
D:GLY129
|
4.2
|
32.1
|
1.0
|
C15
|
D:R7X301
|
4.3
|
46.2
|
1.0
|
NH2
|
D:ARG137
|
4.3
|
54.4
|
1.0
|
CE1
|
D:HIS24
|
4.3
|
30.8
|
1.0
|
C17
|
D:R7X301
|
4.4
|
43.4
|
1.0
|
O
|
D:HIS24
|
4.4
|
30.5
|
1.0
|
C
|
D:TRP128
|
4.4
|
25.7
|
1.0
|
CG1
|
D:ILE130
|
4.6
|
38.4
|
1.0
|
N
|
D:GLY129
|
4.6
|
30.1
|
1.0
|
NH1
|
D:ARG137
|
4.7
|
50.2
|
1.0
|
C
|
D:LYS180
|
4.8
|
30.5
|
1.0
|
CA
|
D:ARG137
|
4.8
|
42.9
|
1.0
|
C16
|
D:R7X301
|
4.9
|
42.7
|
1.0
|
N
|
D:GLY181
|
4.9
|
28.4
|
1.0
|
|
Reference:
W.Zhang,
M.Wu,
S.Vadlakonda,
L.Juarez,
X.Cheng,
S.Muppa,
V.Chintareddy,
L.Vogeti,
D.Kellogg-Yelder,
J.Williams,
K.Polach,
X.Chen,
K.Raman,
Y.S.Babu,
P.Kotian.
Scaffold Hopping Via Ring Opening Enables Identification of Acyclic Compounds As New Complement Factor D Inhibitors. Bioorg.Med.Chem. V. 74 17034 2022.
ISSN: ESSN 1464-3391
PubMed: 36272185
DOI: 10.1016/J.BMC.2022.117034
Page generated: Thu Jul 11 05:02:38 2024
|